These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 6169607)
1. [Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. In pathologically verified lung cancer. II. In thrombotic/embolic occurrences]. Bube FW; Egenolf F Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):447-54. PubMed ID: 6169607 [TBL] [Abstract][Full Text] [Related]
2. [Biological surveillance of streptokinase treatment]. Juhan I; Sampol J; Léonetti J; Mathieu P; Muratore R; Serradimigni A Coeur Med Interne; 1978; 17(1):49-55. PubMed ID: 639488 [No Abstract] [Full Text] [Related]
3. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases]. Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV Vasa; 1976; 5(4):332-7. PubMed ID: 1007541 [No Abstract] [Full Text] [Related]
4. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products. Chen JP; Williams TK; Legendre AM Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573 [TBL] [Abstract][Full Text] [Related]
5. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation. Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692 [TBL] [Abstract][Full Text] [Related]
7. [The effect of chemotherapy treatment on hemostasis of patients with lung cancer]. Vorob'eva EO; Akhvlediani M; Emukhvari MG; Sharashidze NA; Gzirishvili LM Georgian Med News; 2008 Sep; (162):40-6. PubMed ID: 18830029 [TBL] [Abstract][Full Text] [Related]
8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355 [TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer. Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin]. Heene DL; Genth K Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262 [No Abstract] [Full Text] [Related]
11. [Hemostasis and antithrombotic therapy in massive thromboembolism of pulmonary artery]. Krashutskiĭ VV; Proskurin VM; Afanas'ev BG Klin Med (Mosk); 1998; 76(1):14-8. PubMed ID: 9532907 [TBL] [Abstract][Full Text] [Related]
12. Nonvalvular atrial fibrillation: evidence for a prothrombotic state. Kahn SR; Solymoss S; Flegel KM CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553 [TBL] [Abstract][Full Text] [Related]
14. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267 [TBL] [Abstract][Full Text] [Related]
15. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase. Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852 [TBL] [Abstract][Full Text] [Related]
16. [Clinical use of thrombolytic agents]. Laprevote-Heully MC; Lambert H; Larcan A Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511 [No Abstract] [Full Text] [Related]
17. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306 [TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis in combined measures to prevent postoperative thromboembolic complications in cancer patients]. Tarabykin AA; Kliachkin BM; Basargin ST Anesteziol Reanimatol; 1990; (1):55-7. PubMed ID: 2350050 [TBL] [Abstract][Full Text] [Related]
19. Comparative sensitivity of different methods to detect and quantify circulating fibrinogen/fibrin split products. Drewinko B; Surgeon J; Cobb P; Callahan L; Schmidt D; Bollinger P; Trujillo JM Am J Clin Pathol; 1985 Jul; 84(1):58-66. PubMed ID: 3893094 [TBL] [Abstract][Full Text] [Related]